Back to companies
ALNYLAM PHARMACEUTICALS, INC.
ALNYUSNASDAQPharmaceuticals & HealthcareALNYLAM PHARMACEUTICALS, INC.
Revenue
$3.7bn
YoY +65.2%
Operating income
$501.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API